Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic ControlĀ® Platform
Go back to Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic ControlĀ® Platform| (NASDAQ: FHTX) | Delayed: 6.22 -0.47 (7.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.69 | 52 Week High | $ | |||
| Open | $6.68 | 52 Week Low | $ | |||
| Day High | $6.80 | P/E | N/A | |||
| Day Low | $6.08 | EPS | $ | |||
| Volume | 433,028 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1176.10 -13.31 (1.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1189.41 | 52 Week High | $88.16 | |||
| Open | $1182.25 | 52 Week Low | $67.88 | |||
| Day High | $1190.11 | P/E | 272.25 | |||
| Day Low | $1171.71 | EPS | $4.32 | |||
| Volume | 2,734,218 | |||||

